MPR's medical analyst Dr. Jon Hallberg discussed the huge variations in prices for treatment at U.S. hospitals with Tom Crann of All Things Considered.
About 10 percent of people suffer from migraine headaches at some time in their life, according to the Migraine Research Foundation. But women are more than three-times more likely to suffer from migraines than men.
Most medical schools require that prospective students score well on a test called the Medical College Admission Test. Starting in 2015, that test will include more questions dealing with the psychological and social basis of medicine.
Tom Crann of All Things Considered spoke with Dr. Jon Hallberg on Wednesday about correlations between obesity and cancer, as well as a connection between depression and sleep disorders.
New medical developments this baseball season protect players from concussions and screen for performance-enhancing substances.
MPR's medical analyst Dr. Jon Hallberg discussed the medical roots of the Iditarod with Tom Crann of All Things Considered.
A new study confirms that standard tests like colonoscopies and removal of precancerous polyps are effective in reducing colon cancer deaths.
A recent study found that the common antibiotic is no more effective in treating sinus infections than placebos.
MPR's medical analyst tells how the vital organ works and whether there's any truth to the idea that a person can die of a broken heart.
Many people are turning to the Internet for help in diagnosing medical symptoms or finding information about a specific disease, according to a study from the Pew Internet and American Life Project.
As millions of baby boomers approach retirement age, medical researchers are exploring how the brain ages and the links between healthy living and memory retention.
There's a new call to reduce deaths, infections and injuries caused by surgical and hospital errors in outpatient procedures.
Medical analyst Dr. Jon Hallberg answers questions about Medicare, eating fish and Lipitor.
How effective have primary care providers been in controlling obesity and its associated medical problems?
The medical world is reacting to the Food and Drug Administration's decision last week to revoke its recommendation of a prominent cancer drug for use against breast cancer. MPR's medical analyst Dr. Jon Hallberg spoke to All Things Considered host Tom Crann about the drug and the FDA's decision.